Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - thickness
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - thickness
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Alanine aminotransferase
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.854
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - back
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - back
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVPWd
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVPWd
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
3.29×10-06
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / RR
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / RR
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000203
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - whole body
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - whole body
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Trunk curl
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Trunk curl
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Creatinine
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Creatinine
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.505
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of thoracic vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean cell hemoglobin concentration
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean cell hemoglobin concentration
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.135
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Eosinophils
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Eosinophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight before experiment
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight before experiment
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Pre-cue freezing total
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Pre-cue freezing total
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.207
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Radius
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Heart weight normalised against body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Heart weight normalised against body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total food intake
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total food intake
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.760
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Context freezing total
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Context freezing total
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.373
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fibula
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Eosinophil differential count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Eosinophil differential count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.967
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Percentage center time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Percentage center time
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.505
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Shape of vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 6kHz-evoked ABR Threshold
|
HET
|
7f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0376
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 6kHz-evoked ABR Threshold
|
HOM
|
3f:1m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0526
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Brachydactyly
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration cue-2
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration cue-2
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body length
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body length
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.980
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - presence
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - presence
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thyroid
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower teeth appearance
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower teeth appearance
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Scapulae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Vocalization
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Vocalization
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of Rears
|
HOM
|
12f:4m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of Rears
|
HET
|
28f:32m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - back paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - back paws
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD62L+ T-Regs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD62L+ T-Regs
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery distance travelled
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery distance travelled
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.677
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT cells (panel A)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Zygomatic bone
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spleen
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration habituation
|
HET
|
14f:16m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration habituation
|
HOM
|
6f:2m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Calcium
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Calcium
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.221
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B1B Cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B1B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / HR
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / HR
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.424
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK KLRG1+ cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK KLRG1+ cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Percentage center movement time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Percentage center movement time
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.526
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Shape of ribs
|
HET
|
5f:5m
|
Fisher Exact Test framework
|
0.177
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail elevation
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail elevation
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Epididymis
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Contact righting
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Contact righting
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / Number of signals
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / Number of signals
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Hematocrit
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Hematocrit
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00310
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - number
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - ear
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - ear
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength normalised against body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength normalised against body weight
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.926
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Esophagus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - head
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - head
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Area under glucose response curve
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00397
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - abdomen
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - abdomen
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1_S
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1_S
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat mass
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0382
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI3
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI3
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00185
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration habituation-2
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration habituation-2
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.938
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 30kHz-evoked ABR Threshold
|
HET
|
7f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0383
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 30kHz-evoked ABR Threshold
|
HOM
|
3f:1m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0383
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Phosphorus
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Phosphorus
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0191
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tremor
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tremor
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - morphology
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - morphology
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / RP Macrophage (F4/80+)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Viability Primary Screen / Viability Outcome
|
HOM
|
f:m
|
Supplied as data
|
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Large Unstained Cell (LUC) count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Large Unstained Cell (LUC) count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0605
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Brain
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lymph node
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total water intake
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total water intake
|
HET
|
6f:7m
|
Linear Mixed Model framework, LME, including Weight
|
0.0595
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ CD4+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ CD4+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Lymphocyte cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Lymphocyte cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.965
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head morphology
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / ST
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / ST
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.395
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper teeth appearance
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper teeth appearance
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Body Weight
|
HET
|
6f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Body Weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center distance travelled
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center distance travelled
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.910
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 18kHz-evoked ABR Threshold
|
HET
|
7f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0335
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 18kHz-evoked ABR Threshold
|
HOM
|
3f:1m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0335
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Triglycerides
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Triglycerides
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.761
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration pre-cue
|
HOM
|
6f:2m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration pre-cue
|
HET
|
14f:16m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Clavicle
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT DN KLRG1+ cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT DN KLRG1+ cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Weight / Body weight curve
|
HET
|
66f:74m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Weight / Body weight curve
|
HOM
|
27f:9m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-1
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-1
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.406
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / Body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Platelet count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Platelet count
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0668
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Activity (body position)
|
HET
|
7f:8m
|
Fisher Exact Test framework
|
0.619
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Activity (body position)
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP1
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Liver
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Monocytes
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Monocytes
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration habituation-1
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration habituation-1
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.184
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative food intake
|
HOM
|
66f:22m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative food intake
|
HET
|
154f:176m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Digit integrity
|
HET
|
5f:5m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Thymus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - snout
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - snout
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total protein
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total protein
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0748
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - position
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - position
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Fat/Body weight
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0114
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T Cells (panel B)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD44+ T-Regs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD44+ T-Regs
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Follicular B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Follicular B Cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of cervical vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Latency to center entry
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Latency to center entry
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00812
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Jump
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Jump
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fusion of vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVIDd
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVIDd
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.375
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Mammary gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - morphology
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - morphology
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Tibia
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - abdomen
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - abdomen
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Aspartate aminotransferase
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.413
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - length
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - length
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Eosinophil cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Eosinophil cell count
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.0758
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vocalization
|
HET
|
7f:8m
|
Fisher Exact Test framework
|
0.623
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vocalization
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / cDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / cDCs
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement mean
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement mean
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.313
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Hemoglobin
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Hemoglobin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00213
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative water intake
|
HOM
|
66f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Cumulative water intake
|
HET
|
132f:154m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Syndactylism
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena resting time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena resting time
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.784
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Teeth presence
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Teeth presence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength normalised against body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength normalised against body weight
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.480
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - back
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - back
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center average speed
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center average speed
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.000336
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Challenge Whole Body Plethysmography / Enhanced pause (Penh)
|
HET
|
432f:499m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Challenge Whole Body Plethysmography / Enhanced pause (Penh)
|
HOM
|
216f:72m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK cells (panel A)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B2B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B2B Cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Heart weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Heart weight
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.323
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Alive
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD24+ CD8 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD24+ CD8 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Content (excluding skull)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.728
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Neutrophil differential count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Neutrophil differential count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.578
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - snout
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - snout
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Prostate
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - back
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - back
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skin
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Spleen weight
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Spleen weight
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel B
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel B
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / HDL-cholesterol
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / HDL-cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00410
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Lung
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI2
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI2
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00182
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - S
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - S
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000728
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HOM
|
15f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Blood glucose concentration
|
HET
|
30f:40m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Type of response
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Type of response
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery average speed
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery average speed
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.455
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Processes on vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration cue
|
HOM
|
6f:2m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration cue
|
HET
|
14f:16m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fertility of Homozygous Knock-out Mice / Gross Findings Male
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Maxilla/Pre-maxilla
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Context freezing total
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Context freezing total
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.383
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Transfer arousal
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Transfer arousal
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Lymphocyte differential count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Lymphocyte differential count
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.0750
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Pancreas
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Mouth morphology
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Mouth morphology
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44-CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Neutrophils
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Neutrophils
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Monocyte differential count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Monocyte differential count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0164
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head bobbing
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Head bobbing
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-2
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-2
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.556
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Tibia length
|
HET
|
5f:5m
|
Linear Mixed Model framework, LME, including Weight
|
0.187
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Sample clotted
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Sample clotted
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Spinal cord
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean/Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean/Body weight
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0174
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of ribs right
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - ear
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - ear
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Distance travelled - total
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Distance travelled - total
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.678
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Jump response
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Jump response
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Snout size
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Snout size
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / PR
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / PR
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
9.85×10-08
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel A
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Total number of acquired events in Panel A
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 24kHz-evoked ABR Threshold
|
HOM
|
3f:1m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0431
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 24kHz-evoked ABR Threshold
|
HET
|
7f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0431
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total cholesterol
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00464
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery permanence time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery permanence time
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.505
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Cholesterol ratio
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Cholesterol ratio
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.183
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Albumin
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Albumin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0727
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - length
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - length
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Others
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Others
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Initial response to glucose challenge
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00117
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / HR
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / HR
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00277
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVAWd
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVAWd
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.113
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Aggression
|
HET
|
7f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Aggression
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of center entries
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of center entries
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.923
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Pelvis
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Startle response
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Startle response
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength measurement mean
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength measurement mean
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.662
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Adrenal gland
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel B
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel B
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Latency to fall
|
HET
|
21f:24m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Latency to fall
|
HOM
|
9f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - BN
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - BN
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Urinary bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean cell volume
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean cell volume
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.231
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Gall bladder
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - back
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - back
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Femur
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Challenge Whole Body Plethysmography / Tidal volume (TVb)
|
HET
|
432f:496m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Challenge Whole Body Plethysmography / Tidal volume (TVb)
|
HOM
|
214f:72m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center permanence time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center permanence time
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.505
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 12kHz-evoked ABR Threshold
|
HET
|
7f:8m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0327
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Auditory Brain Stem Response / 12kHz-evoked ABR Threshold
|
HOM
|
3f:1m
|
Reference Range Plus Test framework; quantile = 0.95 (Tails probability = 0.025)
|
0.0526
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength measurement
|
HOM
|
9f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb grip strength measurement
|
HET
|
21f:24m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindpaw - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena permanence
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena permanence
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-2
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-2
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.309
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Basophil cell count
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Basophil cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Mineral Density (excluding skull)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.978
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper lip morphology
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Upper lip morphology
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Red blood cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Red blood cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.00595
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Locomotor activity
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Locomotor activity
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.372
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / cDCs CD11b Type
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / cDCs CD11b Type
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / LIH (Hemolysis Severity - available on AU analysers)
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Skeletal muscle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - tail
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - tail
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Ambulatory activity (no. of beam cuts)
|
HOM
|
66f:22m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Ambulatory activity (no. of beam cuts)
|
HET
|
154f:176m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - appearance
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Vibrissae - appearance
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / MZB
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / MZB
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration cue-1
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration cue-1
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Hot plate latency
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Hot plate latency
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI1
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI1
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.244
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration context
|
HET
|
21f:24m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration context
|
HOM
|
9f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD25- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD25- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD24+ CD4 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD24+ CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Mandibles
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Neutrophil cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Neutrophil cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.457
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT Cells (panel B)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NKT Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Seminal vesicle
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Humerus
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - back paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - back paws
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Large intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Limb grasp
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Limb grasp
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - whole body
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - whole body
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel A
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Percentage of live gated events in Panel A
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of digits
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - abdomen
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - abdomen
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - head
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color pattern - head
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Urea (Blood Urea Nitrogen - BUN)
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.188
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery resting time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Periphery resting time
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.692
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - presence
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Genitalia - presence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of lumbar vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Transitional B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / Transitional B Cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb nail - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Ulna
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - head
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair distribution - head
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Uterus
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ T-Regs
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ T-Regs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Alkaline phosphatase
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.222
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - number
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - length
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - length
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Stomach
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight after experiment
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Body weight after experiment
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Monocyte cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Monocyte cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0872
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of rears - total
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Number of rears - total
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0132
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Unexpected behaviors
|
HET
|
7f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Unexpected behaviors
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Teeth
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-3
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration context-3
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.113
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - Global
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - Global
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.00210
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of ribs left
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD8 CD44-CD62L- T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Distance travelled
|
HOM
|
12f:4m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Distance travelled
|
HET
|
28f:32m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimbs - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - front paws
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin texture - front paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Latency to fall mean
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Latency to fall mean
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.000945
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Area
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Bone Area
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.699
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Cells (panel B)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / NK Cells (panel B)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Weight / Body weight
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Weight / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / QT
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / QT
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.517
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - head
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - color - head
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean corpuscular hemoglobin
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Mean corpuscular hemoglobin
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.905
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVIDs
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / LVIDs
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.183
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DP T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DP T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Cue freezing total
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Cue freezing total
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.341
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Heart Weight / Heart weight normalised against tibia length
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - shape
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Hindlimb digit - shape
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - size
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forepaw - size
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Intraperitoneal glucose tolerance test (IPGTT) / Fasted blood glucose concentration
|
HET
|
6f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0196
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Large Unstained Cell (LUC) differential count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Large Unstained Cell (LUC) differential count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.693
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Heart
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total bilirubin
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Total bilirubin
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.832
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - position
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimbs - position
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total activity (no. of fine movement + no. of beam cuts)
|
HOM
|
66f:22m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Indirect Calorimetry / Total activity (no. of fine movement + no. of beam cuts)
|
HET
|
154f:176m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Fusion of ribs
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Flinch
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Shock Threshold / Shock Intensity Flinch
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3_S
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3_S
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / BMC/Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / BMC/Body weight
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.280
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower lip morphology
|
HOM
|
3f:1m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Lower lip morphology
|
HET
|
8f:8m
|
Fisher Exact Test framework
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Basophil differential count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / Basophil differential count
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.771
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - front paws
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - front paws
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Trachea
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Testes
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - abdomen
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Coat - hair texture / appearance - abdomen
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Body weight
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hot Plate / Body weight
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ CD4 T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / KLRG1+ CD4 T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center resting time
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Center resting time
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.699
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2_S
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP2_S
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Glucose
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Clinical Chemistry / Glucose
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.845
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fertility of Homozygous Knock-out Mice / Gross Findings Female
|
HOM
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Joints
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration post-us
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / Freezing duration post-us
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement
|
HET
|
21f:24m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Grip Strength / Forelimb and hindlimb grip strength measurement
|
HOM
|
9f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Passive rotation
|
HET
|
21f:24m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Rotarod / Passive rotation
|
HOM
|
9f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Skull shape
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / Fractional Shortening
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Echo / Fractional Shortening
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.289
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - number
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb nail - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Gait
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Gait
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / pDCs
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / pDCs
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Kidney
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / QRS
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Electrocardiogram (ECG) / QRS
|
HET
|
7f:8m
|
Linear Model Using Generalized Least Squares framework, GLS, not including Weight
|
0.00326
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Ears
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Ears
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Small intestine
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - number
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Forelimb digit - number
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD25+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD25+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - presence
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Tail - presence
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI4
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / % Pre-pulse inhibition - PPI4
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.0165
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean mass
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Body Composition (DEXA lean/fat) / Lean mass
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, including Weight
|
0.0290
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Tibia length
|
HET
|
5f:5m
|
Linear Model Using Generalized Least Squares framework, GLS, including Weight
|
0.648
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP3
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-1
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Fear Conditioning / % Freezing duration pre-cue-1
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.235
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena average speed
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Open Field / Whole arena average speed
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.283
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4_S
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Acoustic Startle and Pre-pulse Inhibition (PPI) / Response amplitude - PP4_S
|
HET
|
7f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / CD4 CD44+CD62L+ T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
X-ray / Number of pelvic vertebrae
|
HET
|
5f:5m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Ovary
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T cells (panel A)
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / T cells (panel A)
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B Cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / B Cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / DN CD44+CD62L- NKT cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / gd T cells
|
HOM
|
3f:m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Immunophenotyping / gd T cells
|
HET
|
3f:3m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Challenge Whole Body Plethysmography / Frequency of breathing (f)
|
HET
|
432f:494m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Challenge Whole Body Plethysmography / Frequency of breathing (f)
|
HOM
|
213f:72m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / White blood cell count
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Hematology / White blood cell count
|
HET
|
7f:8m
|
Linear Mixed Model framework, LME, not including Weight
|
0.890
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - tail
|
HOM
|
3f:1m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Combined SHIRPA and Dysmorphology / Skin color - tail
|
HET
|
8f:8m
|
|
|
NotProcessed |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |
Cbltm1b(EUCOMM)Hmgu
|
ICS
|
Gross Pathology and Tissue Collection / Eye with optic nerve
|
HET
|
f:m
|
Supplied as data
|
1.00
|
Successful |